ID

12003

Description

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02500706

Link

https://clinicaltrials.gov/show/NCT02500706

Keywords

  1. 8/31/15 8/31/15 -
Copyright Holder

ODM derived from: https://clinicaltrials.gov/show/NCT02500706

Uploaded on

August 31, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT02500706

Eligibility Diabetes NCT02500706

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT02500706
Inclusion Criteria
Description

Inclusion Criteria

male or female, age greater than or equal to 18 years (for japan and taiwan: age greater than or equal to 20 years) at the time of signing informed consent
Description

age greater than or equal to 60 years; informed consent; female; taiwan; japan; time

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0682069
type 1 diabetes mellitus (based on clinical judgement and/or supported by laboratory analysis as per local guidelines) 12 months or more prior to screening
Description

type 1 diabetes mellitus; laboratory; screening; clinical; local; per

Data type

boolean

Alias
UMLS CUI [1]
C0011854
currently treated with a basal-bolus insulin regimen for at least 12 months prior to screening (visit 1)
Description

screening; insulin; regimen; visit

Data type

boolean

Alias
UMLS CUI [1]
C0021641
currently treated with a basal insulin analogue for at least 4 months prior to screening (visit 1)
Description

screening; insulin; visit

Data type

boolean

Alias
UMLS CUI [1]
C0650607
hba1c 7.0-9.5% (53-80 mmol/mol) (both inclusive) as assessed by central laboratory
Description

laboratory; hba1c; both

Data type

boolean

Alias
UMLS CUI [1]
C0019018
body mass index less than or equal to 35.0 kg/m^2
Description

body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

within the past 180 days any of the following: myocardial infarction, stroke or hospitalization for unstable angina and/or transient ischemic attack
Description

myocardial infarction; unstable angina; hospitalization; stroke

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0007787
UMLS CUI [4]
C0038454
subjects presently classified as being in new york heart association (nyha) class iv currently planned coronary, carotid or peripheral artery revascularisation
Description

new york heart association classification; class iv; planned

Data type

boolean

Alias
UMLS CUI [1]
C1882087
UMLS CUI [2]
C3203629
diabetic ketoacidosis requiring hospitalisation within the last 180 days prior to screening (visit 1)
Description

ketoacidosis; screening; diabetic; visit; last

Data type

boolean

Alias
UMLS CUI [1]
C0011880
Inclusion Criteria
Description

Inclusion Criteria

Similar models

Eligibility Diabetes NCT02500706

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT02500706
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
age greater than or equal to 60 years; informed consent; female; taiwan; japan; time
Item
male or female, age greater than or equal to 18 years (for japan and taiwan: age greater than or equal to 20 years) at the time of signing informed consent
boolean
C0001779 (UMLS CUI [1])
C0682069 (UMLS CUI [2])
type 1 diabetes mellitus; laboratory; screening; clinical; local; per
Item
type 1 diabetes mellitus (based on clinical judgement and/or supported by laboratory analysis as per local guidelines) 12 months or more prior to screening
boolean
C0011854 (UMLS CUI [1])
screening; insulin; regimen; visit
Item
currently treated with a basal-bolus insulin regimen for at least 12 months prior to screening (visit 1)
boolean
C0021641 (UMLS CUI [1])
screening; insulin; visit
Item
currently treated with a basal insulin analogue for at least 4 months prior to screening (visit 1)
boolean
C0650607 (UMLS CUI [1])
laboratory; hba1c; both
Item
hba1c 7.0-9.5% (53-80 mmol/mol) (both inclusive) as assessed by central laboratory
boolean
C0019018 (UMLS CUI [1])
body mass index
Item
body mass index less than or equal to 35.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
myocardial infarction; unstable angina; hospitalization; stroke
Item
within the past 180 days any of the following: myocardial infarction, stroke or hospitalization for unstable angina and/or transient ischemic attack
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
new york heart association classification; class iv; planned
Item
subjects presently classified as being in new york heart association (nyha) class iv currently planned coronary, carotid or peripheral artery revascularisation
boolean
C1882087 (UMLS CUI [1])
C3203629 (UMLS CUI [2])
ketoacidosis; screening; diabetic; visit; last
Item
diabetic ketoacidosis requiring hospitalisation within the last 180 days prior to screening (visit 1)
boolean
C0011880 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial